{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:06:20Z","timestamp":1785229580208,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-CoV19-001"],"award-info":[{"award-number":["2022-I2M-CoV19-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejmech.2025.117373","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:19:11Z","timestamp":1738927151000},"page":"117373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis and evolution of 16-membered macrolide carrimycin derivatives as a novel class of anti-HCoV-OC43 agents targeting viral FSE RNA"],"prefix":"10.1016","volume":"287","author":[{"given":"Xiuli","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionglu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonggen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117373_bib1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jama.2020.16337","article-title":"Efficacy of remdesivir in COVID-19","volume":"324","author":"McCreary","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.117373_bib2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/17460441.2022.2153828","article-title":"The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)","volume":"17","author":"Pagliano","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117373_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41586-023-06609-0","article-title":"Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir","volume":"622","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117373_bib4a","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41570-023-00569-9","article-title":"Small molecule approaches to targeting RNA","volume":"8","author":"Kovachka","year":"2024","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.ejmech.2025.117373_bib4b","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","article-title":"Targeting RNA structures with small molecules","volume":"21","author":"Disney","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117373_bib5","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.apsb.2021.02.024","article-title":"Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2","volume":"11","author":"Yan","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117373_bib6","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.apsb.2024.02.023","article-title":"Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed -1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117373_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2020.12.010","article-title":"Programmed \u22121 ribosomal frameshifting in coronaviruses: a therapeutic target","volume":"554","author":"Kelly","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2025.117373_bib8","article-title":"Genomic characterization of a novel SARS-CoV-2","volume":"19","author":"Khailany","year":"2020","journal-title":"Gene Rep"},{"key":"10.1016\/j.ejmech.2025.117373_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/acsmedchemlett.3c00051","article-title":"Discovery of small molecules targeting the frameshifting element RNA in SARS-CoV-2 viral genome","volume":"14","author":"Yang","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117373_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl6096","article-title":"Amilorides inhibit SARS-CoV-2 replication in vitro bytargeting RNA structures","volume":"7","author":"Zafferani","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117373_bib11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.tim.2021.03.018","article-title":"Bacterial coinfections in coronavirus disease 2019","volume":"29","author":"Westblade","year":"2021","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2025.117373_bib12","series-title":"Method for Manufacturing Diacetyl Spiramycin, China Patent CN 1078472A, November 17","author":"Tang","year":"1993"},{"key":"10.1016\/j.ejmech.2025.117373_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ja.2008.127","article-title":"4'''-N-demethylspiramycin derivatives: synthesis and evaluation of effectiveness against drug-resistant bacteria","volume":"61","author":"Sunazuka","year":"2008","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejmech.2025.117373_bib14","first-page":"1","article-title":"Susceptibility of SARS Coronavirus-2 infection in domestic and wild animals: a systematic review","volume":"13","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.ejmech.2025.117373_bib15","first-page":"1","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","author":"Brown","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117373_bib16","first-page":"1","article-title":"Naphthoquine: a potent broad-spectrum anti-coronavirus drug in vitro","volume":"27","author":"Song","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117373_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12038-023-00371-1","article-title":"Characterising ATP binding activity of PilB ATPase of Shewanella oneidensis MR-1 using a molecular modeling and simulations approach","volume":"48","author":"Vaishnav","year":"2023","journal-title":"J. Biosci."},{"key":"10.1016\/j.ejmech.2025.117373_bib18","article-title":"Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway","author":"Zhang","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ejmech.2025.117373_bib19","first-page":"111","article-title":"Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis, Cancer Pathog","volume":"1","author":"Yu","year":"2023","journal-title":"Ther."},{"key":"10.1016\/j.ejmech.2025.117373_bib20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/emboj.2013.135","article-title":"Exonuclease hDIS3L2 specifies an exosome\u2010independent 3\u2032\u20105\u2032 degradation pathway of human cytoplasmic mRNA","volume":"32","author":"Lubas","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.117373_bib21","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1093\/nar\/gkz619","article-title":"The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112","volume":"47","author":"Van","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117373_bib22","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1021\/acs.biochem.8b01160","article-title":"Analysis of the cellular roles of MOCS3 identifies a MOCS3-independent localization of NFS1 at the tips of the centrosome","volume":"58","author":"Neukranz","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117373_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molcel.2021.12.023","article-title":"Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing","volume":"82","author":"Martinez","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.117373_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1091\/mbc.e11-07-0639","article-title":"The kinase activity of human Rio1 is required for final steps of cytoplasmic maturation of 40S subunits","volume":"23","author":"Widmann","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2025.117373_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature12119","article-title":"A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28\u2013let-7 pathway","volume":"497","author":"Chang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117373_bib26","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1261\/rna.040055.113","article-title":"Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs","volume":"19","author":"Ustianenko","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.ejmech.2025.117373_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/15476286.2018.1564466","article-title":"Regulation of RNA decay and cellular function by 3\u2032-5\u2032 exoribonuclease DIS3L2","volume":"16","author":"Luan","year":"2019","journal-title":"RNA Biol."},{"key":"10.1016\/j.ejmech.2025.117373_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-021-00497-4","article-title":"Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7","volume":"6","author":"Xie","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.ejmech.2025.117373_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ja.2008.127","article-title":"4'''-N-demethylspiramycin derivatives: synthesis and evaluation of effectiveness against drug-resistant bacteria","volume":"61","author":"Sunazuka","year":"2008","journal-title":"J. Antibiot (Tokyo)"},{"key":"10.1016\/j.ejmech.2025.117373_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005463","article-title":"Sequence dependency of canonical base pair opening in the DNA double helix","volume":"13","author":"Lindahl","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2025.117373_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nmeth.3658","article-title":"Parmbsc1: a refined force field for DNA simulations","volume":"13","author":"Ivan","year":"2016","journal-title":"Nat. Methods"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:09:56Z","timestamp":1759298996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"alternative-id":["S0223523425001382"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117373","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evolution of 16-membered macrolide carrimycin derivatives as a novel class of anti-HCoV-OC43 agents targeting viral FSE RNA","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117373"}}